GWM Advisors LLC trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 23.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,289 shares of the medical research company’s stock after selling 386 shares during the period. GWM Advisors LLC’s holdings in Thermo Fisher Scientific were worth $261,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of TMO. Capital Research Global Investors boosted its position in Thermo Fisher Scientific by 29.8% during the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after buying an additional 3,973,136 shares during the period. Janus Henderson Group PLC boosted its position in Thermo Fisher Scientific by 2,058.1% during the second quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after buying an additional 2,233,522 shares during the period. Veritas Asset Management LLP boosted its position in Thermo Fisher Scientific by 44.1% during the third quarter. Veritas Asset Management LLP now owns 3,503,259 shares of the medical research company’s stock valued at $662,817,000 after buying an additional 1,072,500 shares during the period. Meritage Group LP purchased a new stake in Thermo Fisher Scientific during the third quarter valued at about $201,383,000. Finally, Capital World Investors boosted its position in Thermo Fisher Scientific by 6.1% during the second quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock valued at $2,051,721,000 after buying an additional 671,637 shares during the period. Institutional investors and hedge funds own 86.11% of the company’s stock.
In related news, insider Patrick M. Durbin sold 6,000 shares of the stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $217.55, for a total value of $1,305,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Stephen Williamson sold 5,000 shares of the stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total transaction of $1,046,300.00. Following the completion of the transaction, the chief financial officer now directly owns 30,741 shares of the company’s stock, valued at $6,432,861.66. The disclosure for this sale can be found here. Over the last three months, insiders sold 94,327 shares of company stock valued at $19,260,542. 0.49% of the stock is owned by insiders.
Several analysts have issued reports on TMO shares. Leerink Swann restated an “outperform” rating and set a $239.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Thursday, February 1st. They noted that the move was a valuation call. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. Evercore ISI started coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price target for the company. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price target for the company in a research report on Tuesday, October 31st. Finally, Bank of America upped their price target on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Two analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $220.50.
Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $210.61 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35. The firm has a market cap of $84,453.55, a PE ratio of 22.22, a PEG ratio of 1.54 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 1-year low of $151.74 and a 1-year high of $226.44.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. Thermo Fisher Scientific’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.41 earnings per share. research analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Thursday, March 15th will be paid a $0.17 dividend. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.71%.
TRADEMARK VIOLATION WARNING: “GWM Advisors LLC Has $261,000 Holdings in Thermo Fisher Scientific Inc. (TMO)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/18/gwm-advisors-llc-has-261000-holdings-in-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.